Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis

Allogeneic hematopoietic stem cell transplant remains the only curative treatment for myelofibrosis. Most post-transplantation events occur during the first two years and hence we aimed to analyze the outcome of 2-year disease-free survivors. A total of 1055 patients with myelofibrosis transplanted...

詳細記述

保存先:
書誌詳細
出版年:Haematologica
主要な著者: Robin, Marie, de Wreede, Liesbeth C., Wolschke, Christine, Schetelig, Johannes, Eikema, Diderik-Jan, Van Lint, Maria Teresa, Knelange, Nina Simone, Beelen, Dietrich, Brecht, Arne, Niederwieser, Dietger, Vitek, Antonin, Bethge, Wolfgang, Arnold, Renate, Finke, Jürgen, Volin, Liisa, Yakoub-Agha, Ibrahim, Nagler, Arnon, Poiré, Xavier, Einsele, Hermann, Chevallier, Patrice, Holler, Ernst, Ljungman, Per, Robinson, Stephen, Radujkovic, Alekxandar, McLornan, Donal, Chalandon, Yves, Kröger, Nicolaus
フォーマット: Artigo
言語:Inglês
出版事項: Ferrata Storti Foundation 2019
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6717573/
https://ncbi.nlm.nih.gov/pubmed/30733269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.205211
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料